• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 921

3'-sialyllactose sodium salt

Intended Use: Intended for use as an ingredient in cow milk-based, non-exempt infant formula for term infants at a level of 0.28 g/L.
Basis: Scientific procedures
Notifier: Jennewein Biotechnologie GmgH
Notifier Address: Maarweg 32
D-53619 Reinbreitbach
GRAS Notice (releasable information): GRN 921 with amendments (in PDF) (2.2 MB)
Date of closure: Oct 30, 2020
FDA's Letter: FDA has no questions (in PDF) (771 kB)